Aspiration Is To Grow In Double Digit With Margin At 26% In FY25: Dr Lal Pathlabs | CNBC TV18
Published 2024-05-12Download video
Recommendations
-
13:14 As Long As There Is Political Continuity, The Market Will Be Ok: Samir Arora | CNBC TV18
-
09:12 Dr Lal Pathlabs: Improvement In Revenue Mix, Company's Plan To Achieve Double Digit Growth In FY25?
-
13:03 Affordable housing: Aavas Financiers
-
05:55 РАКЕТНА НЕБЕЗПЕКА ЧЕРЕЗ МІГ ⚡️ ТРИВОГ БУДЕ БІЛЬШЕ, але...
-
07:19 2-Wheeler Sector Is Bouncing Back Due To Good Demand From Rural Segment: ASK Automotive | CNBC TV18
-
14:26 Commodities Veteran Jeff Currie on 2024 Markets
-
09:16 Positive On The Market As There Is A Strong Probability For NDA To Win 350+ Seats: Carnelian Asset
-
02:28 Q4 Earnings Buzz: Hear From The Management Of Dr Lal Pathlabs, Polycab, Union Bank & Bank Of India
-
22:55 IPO KYC | B2B travel distribution platform TBO Tek | N18V | CNBC TV18
-
09:15 Billionaire investor Ron Baron: Expect Tesla's stock to go up 'huge' now
-
31:19 UTI AMC's Vetri Subramaniam Explains His Big BFSI Bet Despite Sectoral Headwinds | N18V | CNBC TV18
-
09:54 MOFSL inaugurates its 1st tower in Bengaluru, 9 more to come | Mr. Raamdeo Agrawal on CNBC TV18
-
10:18 Suzlon Expects Merger Of Suzlon Global Services To Be Completed In 6-9 Months
-
10:06 Expect Some Select Stocks To Get A Boost If BJP Comes Back To Power: Buoyant Capital | CNBC TV18
-
20:48 2 роки в США по U4U: мої підсумки.
-
03:53 Rakesh Jhunjhunwala's stock picking mantra
-
24:07 Transformers, explained: Understand the model behind ChatGPT
-
10:12 Diagnostics Will Continue To Remain The Mainstay Within Healthcare: Dr Lal Path Labs | CNBC TV18
-
04:31 No Reason To Believe The Market Will Be Any Different In The Next 5 Years: Ramesh Damani
-
08:32 Few Market Themes That Can Do Well Are Capital Goods, Power, Defence & Infra: Axis MF | CNBC TV18
Similar videos